Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled phase IIa study of GST-HG131 tablets in chronic hepatitis B
CTR20233484Phase 2Completed
- Sponsor
- Fujian Cosunter Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GST-HG131 in Chronic Hepatitis B (CHB), sponsored by Fujian Cosunter Pharmaceutical Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
GST-HG131
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20233484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233484.